Complement activation, circulating protease inhibitors and pregnancy-associated proteins in severe pre-eclampsia.
Circulating protease inhibitors, pregnancy-associated proteins and the split product of complement factor 3 (C3d) were measured in 14 women with severe pre-eclampsia and their matched controls. Only the mean levels of antithrombin III were observed to be significantly lower in pre-eclampsia (P less than 0.02).
D000990:Antithrombin III / Q000032:analysis; D003167:Complement Activation; D003176:Complement C3 / Q000032:analysis; D015933:Complement C3d; D005260:Female; D006801:Humans; D011225:Pre-Eclampsia / Q000097:blood*; D011247:Pregnancy; D011257:Pregnancy Proteins / Q000097:blood*; D011268:Pregnancy-Specific beta 1-Glycoproteins / Q000032:analysis; D011480:Protease Inhibitors / Q000097:blood*
D003176:Complement C3; D011257:Pregnancy Proteins; D011268:Pregnancy-Specific beta 1-Glycoproteins; D011480:Protease Inhibitors; D015933:Complement C3d; D000990:Antithrombin III